智通财经APP讯，昊海生物科技(06826)发布公告，关于第二期A股股份回购实施结果，截至2025年8月14日，公司已完成本期回购。公司通过上海证券交易所系统以集中竞价交易方式已累计回购A股股份183.24万股，占公司总股本比例为0.79%，回购成交的最高价为63.58元/股，最低价为49.25元/股，回购均价为56.70元/股，支付的资金总额为人民币1.039亿元(不含印花税、交易佣金等费用)。
智通财经APP讯，昊海生物科技(06826)发布公告，关于第二期A股股份回购实施结果，截至2025年8月14日，公司已完成本期回购。公司通过上海证券交易所系统以集中竞价交易方式已累计回购A股股份183.24万股，占公司总股本比例为0.79%，回购成交的最高价为63.58元/股，最低价为49.25元/股，回购均价为56.70元/股，支付的资金总额为人民币1.039亿元(不含印花税、交易佣金等费用)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.